Bernárdez ZF, Jáuregui MRA, Cabrera CE

Language: Spanish
References: 25
Page: 480-486
PDF size: 1139.55 Kb.

ABSTRACT

Background: A finding of primary malignancies of different histological nature in each ovary is a particularly interesting condition since the information available about it is scarce and because there is hardly any consensus about its definition, classification and proper diagnostictherapeutic approach.
Clinical case: A case of a 49 year-old female patient presenting an abdominal mass with irregular 10 × 10 cm edges that comprises the area between the left illiac fossa and the umbilical scar. An exploratory laparatomy revealed two masses; a 15 cm cystic one in the left ovary, and an 8 cm one in the right ovary. The following histopathological analysis revealed a bilateral papillary carcinoma. A full oncogynecological surgical protocol for ovarian carcinoma was applied. The last histopathological analysis revealed a clear cell carcinoma in the left ovary, and a moderately differentiated endometrioid carcinoma in the right one.
Conclusions: A rare case of a synchronous double primary ovarian tumor is reported. Its clinical presentation, diagnosis, treatment and follow-up pose a particular classification issue.

REFERENCES

1. Consenso Nacional de Cáncer de Ovario. GAMO 2006;5:1-32.

2. Intraperitoneal Chemotherapy for Ovarian Cancer. ACOG. Committee Opinion 2008.

3. Castro IM, Connell PP, Waggoner S, Rotmensch J, Mundt AJ. Synchronous ovarian and endometrial malignancies. Am J Clin Oncol (CCT) 2000;23:521-525.

4. Elishaev E, Gilks CB, Miller D, Srodon M, Kurman RJ, Ronnett BM. Synchronous and metachronous endocervical and ovarian neoplasms. Evidence supporting interpretation of the ovarian neoplasms as metastasic endocervical adenocarcinomas simulating primary ovarian surface epithelial neoplasms. Am J Surg Pathol 2005;29:281-294.

5. Papathanasiou K, Tolikas A, Dovas D, Kostopoulouy E, Fragkedakis N, Tzafettas J. Simultaneously detected primary malignant tumors of ovary and endometrium with unusual histology. Int J Gynecol Cancer 2005;15:1191-1194.

6. Otrock ZK, Mahfouz RAR, Salem AM. Four primary tumors of lung, bladder, prostate and breast in a male patient. South Med J 2005;98:945-948.

7. Thiersch K. Malignant tumours. Popular Science 1976;52:25:142.

8. Billroth T. Die Allgemeine Chirurgische Pathologie and Therapie. In Reimer G, ed. 51 Vorlesungen-Ein Handbuch fur Studierende and Artze, 14. Berlin, Auflage, 1889.

9. Warren S, Gates P. Multiple primary malignant tumors: A survey of the literature and statistical study. Am J Cancer 1932;16:1358-1414.

10. Moertel CG. Karnofsky memorial lecture. An odyssey in the land of small tumors. J Clin Oncol 1987;5:1502-1522.

11. Santander G, Lombardo K, Rodríguez R. Tumores múltiples. Análisis de 25 casos. Salud Militar 2006;28:73-80.

12. Behbakth K, Randall T, Benjamin I, Morgan M, King S, Ribin S. Clinical Characteristics of clear cell carcinoma of the ovary. Gynecol Oncol 1998;70:255-258.

13. Rosales-Aujang E. Quiste gigante de ovario y embarazo. Reporte de un caso y revisión de la bibliografía. Ginecol Obstet Mex 2011;79:235-238.

14. Kennedy AW, Biscotti CV, Hart WR, Webster KD. Ovarian Clear Cell Adenocarcinoma. Gynecol Oncol 1989;32:342-349.

15. Vercellini P, Parazzini F, Bolis G. Endometriosis and ovarian cancer. Am J Obstet Gynecol 1993;169:181-182.

16. Yoshikawa H, Kimbo H, Okada S. Prevalence of endometriosis in ovarian cancer. Gynecol Obstet Invest 2000;50:11-13.

17. Modesitt S, Tortolero-Luna G, Robinson J, Gershenson D, Wolf J. Ovarian and extraovarian endometriosis associated cancer. Obstet Gynecol 2002;100:788 795.

18. Stern R, Dash R, Bentley R, Snyder M, Haney A, Robboy S. Malignancy in endometriosis: frequency and comparison of ovarian and extraovarian types. Int J Gynecmol Pathol 2001;20:133-139.

19. Martí Cardona L. Diagnóstico de las masas anexiales y del cáncer de ovario. En XII Curso Intensivo de Ginecología Oncológica. Madrid 2005. Laboratorios Menarini.

20. Tringler B, Liu W, Corral L, Torkko KC, Enomoto T, Davidson S, Lucia MS, et al. B7-H4 over-expression in ovarian tumors. Gynecol Oncol 2005;24:9-11.

21. Yoshikawa H, Kimbo H, Okada S. Prevalence of endometriosis in ovarian cancer. Gynecol Obstet Invest 2000;50:11.

22. Scully RE. WHO. International Histological Classification of Tumors. Histologic Typing of ovarian Tumors. Berlin: Springer-Verlag 1999.

23. IItamochi H. Kigawa J, Sultana H, Iba T, Akeshima R, Kamazawa S, Kanamori Y, Terakawa N. Sensitivity to anticancer agents and resistance mechanism in clear cell carcinoma of the ovary. Jpn J Cancer Res 2002;93:723-728.

24. Pather S, Quinn MA. Clear Cell cancer of the ovary - is it chemosensitive? Int J Gynecol Cancer 2005;15:432-437.

25. Tammela J, Geisler JP, Eskew PN, Geisler HE. Clear cell carcinoma of the ovary: poor prognosis compared to serous carcinoma. Eur J Gynaecol Oncol 1998; 19(5): 438-440.